000 01283 a2200337 4500
005 20250515090506.0
264 0 _c20080109
008 200801s 0 0 eng d
022 _a0741-238X
024 7 _a10.1007/BF02849967
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKara, Ismail Oguz
245 0 0 _aLevels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
_h[electronic resource]
260 _bAdvances in therapy
_c
300 _a741-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xblood
650 0 4 _aLymphoma, Non-Hodgkin
_xblood
650 0 4 _aLymphoproliferative Disorders
_xblood
650 0 4 _aMeningeal Neoplasms
_xblood
650 0 4 _aMeninges
_xpathology
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xblood
650 0 4 _aPredictive Value of Tests
650 0 4 _aTumor Necrosis Factor Receptor Superfamily, Member 7
_xblood
700 1 _aSahin, Berksoy
700 1 _aGunesacar, Ramazan
773 0 _tAdvances in therapy
_gvol. 24
_gno. 4
_gp. 741-7
856 4 0 _uhttps://doi.org/10.1007/BF02849967
_zAvailable from publisher's website
999 _c17423290
_d17423290